Ordering
Available Variants5 mg
CHA.12010-5mg
Price
€164.00
Available – Dispatch in 14 days
25 mg
CHA.12010-25mg
Price
€631.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.12010-5mg | €164.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.12010-25mg | €631.20 |
≥95% (NMR)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C4H10NO5P · xNa+ · yH2O |
|---|---|
| CAS Number | 66508-53-0 |
| Molecular Weight | 183.10 (anhydrous free acid basis) |
| MDL number | MFCD00865023 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥95% (NMR) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Fosmidomycin sodium salt hydrate, with a CAS number of 66508-37-0, is a synthetic antibiotic that has garnered significant attention for its potent inhibitory activity against various pathogens. This compound functions by targeting the enzyme 1-deoxy-D-xylulose 5-phosphate reductoisomerase, which is essential for the biosynthesis of isoprenoids in certain microorganisms. As a result, fosmidomycin sodium salt hydrate exhibits broad-spectrum antibacterial properties, particularly against Gram-positive and some Gram-negative bacteria. Its mechanism of action is distinct from that of traditional antibiotics, making it a valuable candidate for the development of novel therapeutic agents. Furthermore, fosmidomycin sodium salt hydrate has shown promise in treating diseases caused by multidrug-resistant bacteria, highlighting its potential as a critical component in the fight against antimicrobial resistance. Its unique properties make it an important subject of ongoing research and development in the field of antimicrobial therapy.
